Pfizer Inc. Profile Avatar - Palmy Investing

Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin f…
Drug Manufacturers - General
US, New York [HQ]
Government, Law & Regulation

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Latest Obligations 2024

Contracts
$ -29,842,660.93
0.0 IDVs
$ 1,309,067,155.23
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. 2023
Contracts
$ 15,979,170.14
IDVs
$ 1,380,651,497.87
Direct Payments
$ 0.0
Grants
$ -18,155.62
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
  • No trends presentable at the moment.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

Contract Analysis

n/a = This field was left empty by authority, NIA = National Interest Action

Click a row to load it inside the upper Contract Analysis.

Analyze Agency Type Order Duration Modified At NIA? Competition Total Offers Consolidated?
HHS IDV_B_B Covid-19 Adult … 06/2024 - Open End 05/11/2024 n/a A 6 n/a
VA IDV_C 65 I B, Drugs, … 07/2024 - Open End 05/11/2024 n/a A 999 n/a
HHS IDV_B_B 2024 Adult Vacc… 07/2024 - Open End 21/10/2024 n/a A 8 n/a
HHS IDV_B_B 2024-2025 Vacci… 04/2024 - Open End 21/10/2024 n/a A 5 n/a
VA IDV_B_A New Award For E… 10/2020 - Open End 02/10/2024 n/a A 1 n/a
HHS C The Purpose Of … 09/2024 - 09/2025 30/09/2024 n/a A 4 n/a
VA B Ciprofloxacin .… 09/2024 - 10/2024 25/09/2024 n/a F 6 n/a
HHS IDV_B_B Covid-19 Pediat… 06/2024 - Open End 06/09/2024 n/a A 5 n/a
HHS IDV_B_B Pediatric Covid… 06/2023 - Open End 04/09/2024 n/a A 3 n/a
HHS IDV_B_B Adult Covid-19 … 06/2023 - Open End 04/09/2024 n/a A 4 n/a
VA IDV_E Bpa For Oxybryt… 09/2023 - Open End 29/08/2024 n/a A 1 n/a
DOD IDV_B_B 4610063704!Manu… 09/2020 - Open End 27/08/2024 n/a A 16 n/a
VA IDV_B_A 2 Line Items Fo… 09/2020 - Open End 15/08/2024 n/a A 3 n/a
DOD C 4565360901!Fent… 08/2024 - 08/2024 06/08/2024 n/a A n/a n/a
DOD C 4565360152!Meth… 08/2024 - 08/2024 06/08/2024 n/a A n/a n/a
DOD C 4565360153!Cleo… 08/2024 - 08/2024 06/08/2024 n/a A n/a n/a
DOD C 4565360154!Cyto… 08/2024 - 08/2024 06/08/2024 n/a A n/a n/a
DOD C 4565360895!Morp… 08/2024 - 08/2024 06/08/2024 n/a A n/a n/a
DOD C 4565347668!Morp… 08/2024 - 08/2024 05/08/2024 n/a A n/a n/a
DOD C 4565347666!Fent… 08/2024 - 08/2024 05/08/2024 n/a A n/a n/a
DOD C 4565347664!Mida… 08/2024 - 08/2024 05/08/2024 n/a A n/a n/a
DOD C 4565347665!Mida… 08/2024 - 08/2024 05/08/2024 n/a A n/a n/a
DOD C 4565347661!Fent… 08/2024 - 08/2024 05/08/2024 n/a A n/a n/a
DOD C 4565347660!Morp… 08/2024 - 08/2024 05/08/2024 n/a A n/a n/a
DOD C 4565347662!Estr… 08/2024 - 08/2024 05/08/2024 n/a A n/a n/a
DOD C 4565327928!Mida… 08/2024 - 08/2024 02/08/2024 n/a A n/a n/a
DOJ B Tod-Saso: Auto-… 08/2024 - 07/2025 01/08/2024 n/a F 1 n/a
DOD C 4565317825!Deme… 08/2024 - 08/2024 01/08/2024 n/a A n/a n/a
DOD C 4565306670!Peni… 07/2024 - 08/2024 31/07/2024 n/a A n/a n/a
DOD C 4565291734!Tran… 07/2024 - 08/2024 30/07/2024 n/a A n/a n/a
DOD C 4565291735!Tran… 07/2024 - 08/2024 30/07/2024 n/a A n/a n/a
HHS IDV_B_B Vaccines For Ch… 04/2023 - Open End 15/07/2024 n/a A 5 n/a
HHS IDV_B_B Adult Vaccines … 07/2023 - Open End 26/04/2024 n/a A 7 n/a
VA IDV_B_A New Award For P… 05/2022 - Open End 06/03/2024 n/a A 3 n/a
HHS IDV_B_B Vaccines For Ad… 07/2022 - Open End 15/02/2024 n/a A 6 n/a
HHS IDV_B_B Vaccines For Ch… 04/2022 - Open End 14/06/2023 NONE A 5 n/a
HHS IDV_B_B Pfizer Vaccines… 08/2022 - Open End 22/09/2022 NONE C 1 n/a
HHS IDV_B_B Vaccines For Ch… 04/2021 - Open End 27/07/2022 NONE A 5 n/a
HHS IDV_E Sterile Water 2… 04/2021 - Open End 22/06/2022 NONE None n/a n/a
HHS IDV_B_B 2021 Vaccines F… 06/2021 - Open End 28/04/2022 NONE A 6 n/a
End of PFE's Analysis
CIK: 78003 CUSIP: 717081103 ISIN: US7170811035 LEI: - UEI: MHBQULRMEEJ5
Secondary Listings